<< back
ReachX logo

COVID-19 - Biopharma’s agility put at test


Publication Date: 25 Mar 2020 - By Scitaris GmbH By Scitaris G.

Thematic Multi Asset Global Pharmaceuticals Biotechnology


Scitaris, a leading biotech and pharma consultancy, is providing a perspective on the biological characteristics of the virus, including:

- implications on its transmission and potential ends to the pandemic

- focusing the race of the biopharma industry to finding a cure

- considerations for investors in the space

Scitaris Covid -19

Source: Scitaris

Pages: 6

Released: 25 Mar 2020

Download Report

The Author

Scitaris G.

Pharmaceuticals, Healthcare, Biotechnology


Most read